欢迎来到天天文库
浏览记录
ID:46636394
大小:622.53 KB
页数:3页
时间:2019-11-26
《07伏立康唑患者血药浓度的监测》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、622中国临床药理学杂志第29卷第8期2013年8月(总第166期)伏立康唑患者血药浓度的监测Voriconazoleplasmaconcentrationmonitoringinpatients1a,21a1a付双双,熊歆,段京莉,摘要:目的监测患者伏立康唑血药浓度,探索伏立康唑谷浓度与临床疗效和不1a1b1b良反应的关系。方法通过液质联用方法测定患者使用伏立康唑的谷浓度,并王瓅珏,刘彦,景红梅,翟所迪1a观察患者治疗期间的疗效和不良反应发生的情况。结果共纳入17例患者,其-1-1伏立康唑的谷浓度
2、中位数为3畅92μg·mL(0畅71~7畅38μg·mL)。其中14人好转,3人治疗无效。共7人发生药物不良反应,其中5例为肝功能异常,2例为视觉障碍,1例出现幻觉,1名患者同时发生肝功异常和视觉障碍,该7名患者(1畅北京大学第三医院,a畅药剂科;b畅血液科,-1的血药浓度中位数为4畅80μg·mL。结论伏立康唑浓度个体间差异大,可北京100191;2畅北京大学药学院,北京100191)预测性差,需对ICU和血液科严重侵袭性真菌病患者监测伏立康唑血药浓度。-1伏立康唑血药浓度大于4畅80μg·mL时
3、,更容易发生药物不良反应。关键词:伏立康唑;治疗药物监测;谷浓度;药物不良反应1a,2FUShuang-shuang,中图分类号:R978畅5;R969畅1文献标志码:A1a1a文章编号:1001-6821(2013)08-0622-03XIONGXin,DUANJing-li,1a1bWANGLi-jue,LIUYan,JINGHong-mei1b,ZHAISuo-di1aAbstract:ObjectiveTodeterminetheplasmaconcentrationsofvori-cona
4、zoleofinpatients,andaccesstheassociationbetweenthetroughcon-centrationsandclinicaleffectivenessandadversedrugreactions畅Meth-odsThetroughconcentrationswereanalyzedbyLC-MS/MS畅The(1畅a畅DepartmentofPharmacy;clinicaleffectivenessandadversedrugreactionsduring
5、thepharmacother-b畅DepartmentofHematology,Pekingapyperiodwereobserved畅ResultsAtotalof17patientswereenrolledUniversityThirdHospital,Beijingandtheirtroughconcentrationsofvoriconazoleweredetermined畅Theme-100191,China;2畅SchoolofPharma--1ceuticalSciences,Pek
6、ingUniversity,dianconcentrationwas3畅92μg·mL(concentrationrangewas0畅71--1Beijing100191,China)7畅38μg·mL)畅Therewere14patientscompletelyorpartialrespon-dingtotheanti-fungaltherapyand3failingtoresponding畅Anumberof7patientsexperiencedvoriconazole-relateddrug
7、adversereactions,and5ofthemwereliverabnormalities,2ofthemwerevisualdisturbances,and1wasneurotoxicity畅Themedianconcentrationofthoseexperienced-1adversedrugreactionswas4畅80μg·mL畅ConclusionHighconcen-trationvariabilitywasobservedamongpatients,androutinemo
8、nitoringofvoriconazolebloodlevelmayimprovethedrugsafety畅Voriconazolecon--1centrationover4畅80μg·mLisrelatedtoahigherproportionofad-versedrugreaction畅Keywords:voriconazole;therapeuticdrugmonitoring;troughconcen-收稿日期:2013-03-19tration;adve
此文档下载收益归作者所有